TWP
PDSB icon

Tempus Wealth Planning’s PDS Biotechnology PDSB Stock Holding History

Tempus Wealth Planning’s Portfolio PDSB Stock Details PDSB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$37.4K Hold
61,800
– – 0.01% 270
2025
Q4 		$47.6K Buy
61,800
+14,000
+29% +$12.6K 0.01% 274
2025
Q3 		$48.3K Hold
47,800
– – 0.01% 275
2025
Q2 		$63.6K Buy
47,800
+29,000
+154% +$39.4K 0.02% 259
2025
Q1 		$22.4K Hold
18,800
– – 0.01% 252
2024
Q4 		$30.6K Hold
18,800
– – 0.01% 246
2024
Q3 		$71.8K Hold
18,800
– – 0.03% 219
2024
Q2 		$55.1K Buy
+18,800
New +$60.2K 0.02% 205

Other funds holding PDSB

VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
IWA
Inspirion Wealth Advisors Libertyville, Illinois $874M AUM 16.23% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Tempus Wealth Planning's PDSB Position: Q1 2026 in Review

Tempus Wealth Planning held its PDS Biotechnology (PDSB) position steady in Q1 2026 at 61,800 shares worth $37.4K. The position accounts for 0.01% of the portfolio, ranked #270.

Tempus Wealth Planning first reported a position in PDSB in Q2 2024 and has held it in 8 quarters since. The position peaked at $71.8K in Q3 2024. 41 funds tracked by Wall St. Rank hold PDSB as of Q1 2026.

  • Tempus Wealth Planning held 61,800 shares of PDS Biotechnology worth $37.4K as of Q1 2026.
  • Tempus Wealth Planning left its PDS Biotechnology share count unchanged in Q1 2026.
  • PDS Biotechnology made up 0.01% of Tempus Wealth Planning's portfolio in Q1 2026, its #270 holding.
  • Tempus Wealth Planning first reported a position in PDS Biotechnology in Q2 2024 and has held it in 8 quarters since.
  • Tempus Wealth Planning's PDS Biotechnology position peaked at $71.8K in Q3 2024.
  • 41 funds tracked by Wall St. Rank held PDS Biotechnology as of Q1 2026.

Based on Tempus Wealth Planning's 13F filing for Q1 2026, filed 29 Apr 2026.